These scientific and medical publications are provided for educational purposes only.

Jun 2023

Phase 2 study of TAVT-119 (amlodipine besylate) gel in patients with chronic anal fissure.

Jun 2023

A novel abiraterone acetate oral suspension for patients with metastatic prostate cancer: An open-label phase 3 randomized trial.

Apr 2023

In vitro pharmacological characterization of TAVT-135, a novel chloride ion transporter for pan-genotypic treatment of cystic fibrosis.

Mar 2023

TAVT-135, a novel chloride ion transporter for the pan-genotypic treatment of cystic fibrosis: electrophysiological and mucus-hydration properties.

Nov 2022

In vitro evaluation of TAVT-135, an artificial pan-genotypic chloride ion transporter.

Dec 2021

Dose finding and food effect studies of a novel abiraterone acetate formulation for oral suspension in comparison to a reference formulation in healthy male subjects.

Dec 2019

Dose Escalation Study to Assess the Pharmacokinetic Parameters of a Nano-amorphous Oral Sirolimus Formulation in Healthy Volunteers

May 2019

Nano-amorphous oral sirolimus formulation exhibits low inter-individual variability and improved exposure